KM plotter / Kaplan-Meier plotter
Assesses the effect of genes on survival using cancer samples. KM plotter is a web application, developed for meta-analysis-based biomarker assessment, that can be used for breast, ovarian, lung, gastric, and liver cancer. The software includes patients with a mean follow-up of 69 / 40/ 49 /33 months. The subtool miRpower enables the validation of the prognostic relevance of microRNAs (miRNAs) in breast and liver cancer.